Unknown: Category c, unknown risk in humans during pregnancy or breast feeding. Animal studies have suggested risks. It is a topical drug but common side effects suggest absorbtion. Risk will have to be weighed against benefits by the patient and her doctor.
Answered 10/4/2016
6.3k views
Probably: While any drug taken during pregnancy has the potential to negatively affect the fetus, calcineurin inhibitors like tacrolimus and pimecrolimus are considered category c drugs, which means that they have not been associated with fetal loss or birth defects in animal studies. However, category c also means that these drugs have not been well studies in humans, so there may be potential risks.
Answered 11/7/2015
5k views
A doctor has provided 1 answer
4 doctors weighed in across 2 answers
A doctor has provided 1 answer
A doctor has provided 1 answer
A doctor has provided 1 answer
90,000 U.S. doctors in 147 specialties are here to answer your questions or offer you advice, prescriptions, and more.
Ask your question